Understand the significance of family history of skin cancer (F) in clinical documentation and medical coding. Learn about genetic predisposition to skin cancer and hereditary skin cancer risk assessment for accurate diagnosis and patient care. Explore resources for documenting family history of skin cancer (F) and its implications for personalized treatment plans.
Also known as
Family history of malignant neoplasm of skin
Personal history of family member with skin cancer.
Genetic susceptibility to malignant neoplasm
Increased risk of cancer due to inherited genes.
Family history of malignant neoplasm
Family member has had any type of cancer.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the skin cancer melanoma?
Yes
Is personal history of melanoma present?
No
Is personal history of non-melanoma skin cancer present?
When to use each related code
| Description |
|---|
| Family history increases skin cancer risk. |
| Personal history of skin cancer. |
| Multiple dysplastic nevi (atypical moles). |
Lack of specific skin cancer type in family history documentation leads to coding ambiguity and potential underreporting of risk.
Discrepancies between patient-reported and documented family history can impact accurate risk assessment and coding selection for F codes.
Coding family history based on unconfirmed patient statements without supporting documentation poses audit risks and CDI queries.
Q: How can I effectively assess a patient's family history of skin cancer to determine their individual risk of developing melanoma or non-melanoma skin cancers?
A: Accurately assessing a patient's family history of skin cancer is crucial for personalized risk stratification and preventative strategies. A detailed family history should include first-degree relatives (parents, siblings, children) and second-degree relatives (grandparents, aunts, uncles) with skin cancer, noting the specific type of skin cancer (melanoma, basal cell carcinoma, squamous cell carcinoma), age of onset, and any associated genetic syndromes (e.g., familial atypical multiple mole melanoma syndrome). Incorporate questions about sun exposure habits and phenotypic characteristics like skin type, hair color, and eye color to refine risk assessment. Explore how standardized questionnaires and risk prediction tools, such as the Melanoma Risk Assessment Tool, can be integrated into your practice to facilitate comprehensive risk evaluation. Consider implementing a family pedigree or genogram to visualize inherited patterns and identify patients who may benefit from genetic counseling and/or testing for high-penetrance melanoma susceptibility genes like CDKN2A.
Q: What genetic tests are available for identifying hereditary skin cancer risk, and when should I recommend them to my patients with a family history of skin cancer?
A: Several genetic tests are available to assess hereditary skin cancer risk, primarily focusing on genes associated with melanoma susceptibility, such as CDKN2A, CDK4, and BAP1. Genetic testing should be considered for patients with a strong family history of melanoma, especially multiple affected family members, early-onset melanoma, multiple primary melanomas in an individual, or a family history of pancreatic cancer or other cancers linked to CDKN2A mutations. For patients with a family history of basal cell carcinoma, genetic testing may be considered for those with features of basal cell nevus syndrome (Gorlin syndrome), particularly PTCH1 mutations. It's essential to pre-test genetic counseling to discuss the benefits, limitations, and potential implications of genetic testing. Learn more about genetic testing guidelines from the National Comprehensive Cancer Network (NCCN) for appropriate patient selection and interpretation of results.
Patient presents with concerns regarding family history of skin cancer, specifically noting multiple first-degree relatives diagnosed with melanoma and basal cell carcinoma. The patient denies any personal history of skin cancer but expresses significant anxiety about developing the disease given their genetic predisposition. Physical examination reveals no suspicious lesions at this time. Patient education provided on sun protection strategies, including regular sunscreen use with a high SPF, protective clothing, and limiting sun exposure during peak hours. Discussed the importance of regular skin self-exams and professional skin cancer screenings given the family history of skin cancer and increased risk. Genetic counseling may be considered for further risk assessment and management. Diagnosis of family history of skin cancer, also known as hereditary skin cancer risk or genetic predisposition to skin cancer, was established. ICD-10 code Z83.71 (family history of malignant neoplasm of skin) is documented for medical billing and coding purposes. Follow-up scheduled in six months for repeat skin examination and ongoing risk assessment. Patient advised to return sooner if any new or changing skin lesions are noted.